A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
Phase 1 Terminated
14 enrolled 10 charts
Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
Phase 1 Terminated
4 enrolled 6 charts
Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Phase 1 Terminated
35 enrolled 28 charts
A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
Phase 1 Terminated
65 enrolled
First in Patient Study for PF-06840003 in Malignant Gliomas
Phase 1 Terminated
17 enrolled 35 charts
Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I
Phase 1 Terminated
24 enrolled
Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
Phase 1 Terminated
26 enrolled
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
Phase 1 Terminated
2 enrolled
Melphalan With BBBD in Treating Patients With Brain Malignancies
Phase 1 Terminated
21 enrolled
Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
Phase 1 Terminated
6 enrolled
Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
Phase 1 Terminated
2 enrolled
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
Phase 1 Terminated
129 enrolled
RO4929097 in Treating Patients With Recurrent Invasive Gliomas
Phase 1 Terminated
22 enrolled
Bortezomib in Treating Patients With Recurrent Glioma
Phase 1 Terminated
42 enrolled
MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer
Phase 1 Terminated
33 enrolled
VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma
Phase 1 Terminated
14 enrolled
Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
Phase 1 Terminated
19 enrolled
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Terminated
8 enrolled
SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
Phase 1 Terminated
33 enrolled